Israeli Agricultural Technology Firm Kaiima Raises $65M | GenomeWeb

NEW YORK (GenomeWeb News) – Israeli seed and breeding technology firm Kaiima Bio Agri-Tech today announced it closed on a financing round that raised US$65 million.

Three new investors participated in the round — Horizons Ventures; the International Financial Corporation, a member of the World Bank Group; and the Infinity Group. Participating existing investors included Draper Fisher Jurvetson; DFJ-Tamir Fishman Ventures; Mitsui Global Investment; Kleiner Perkins Caufield & Byers; Oberlee; and Musea Ventures.

Kaiima did not specify how the financing will be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.